Joseph M. Casper - 27 Jan 2026 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role: Chief Operating Officer
Signature: /s/ Joseph M. Casper
Issuer symbol: NRXP
Transactions as of: 27 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 17 Feb 2026, 19:00:43 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Casper Joseph Michael	Chief Operating Officer	C/O NRX PHARMACEUTICALS, INC., 1201 ORANGE STREET, SUITE 600, WILMINGTON	/s/ Joseph M. Casper	17 Feb 2026	0002106955

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NRXP	Stock Option (right to buy)	Award	$0	+100,000		$0.000000	100,000	27 Jan 2026	Common Stock	100,000	$2.39	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. 33.3% of the Options shall vest on June 1, 2026, 33.3% shall vest on December 1, 2026, and the remaining 33.3% shall vest on December 1, 2027.